This study reveals that METTL1 plays an important role in driving cardiac hypertrophy by regulating the SRSF9/NFATc4 axis, suggesting that targeting METTL1 could be an efficient way to treat cardiac hypertrophy and HF. The gene discussed is NFATC4; the disease is cardiac hypertrophy.